早幼粒細胞白血病蛋白

位於15號人類染色體的基因

早幼粒細胞白血病蛋白是指可能的轉錄因子可能的轉錄因子(英語:Probable transcription factor PML),是一個由人類基因 PML 編碼的抑癌蛋白。

Promyelocytic leukemia
早幼粒細胞白血病蛋白
PDB rendering based on 1bor.
有效結構
PDB 直系同源檢索:PDBe, RCSB
標識
代號 PML; MYL; PP8675; RNF71; TRIM19
擴展標識 遺傳學102578 鼠基因104662 同源基因13245 GeneCards: PML Gene
直系同源體
物種 人類 小鼠
Entrez 5371 18854
Ensembl ENSG00000140464 ENSMUSG00000036986
UniProt P29590 Q60953
mRNA序列 NM_002675 NM_008884
蛋白序列 NP_002666 NP_032910
基因位置 Chr 15:
74.29 – 74.34 Mb
Chr 9:
58.22 – 58.25 Mb
PubMed查詢 [1] [2]

功能

互作

早幼粒細胞白血病蛋白可與下列蛋白質發生交互作用

參見

參考文獻

  1. ^ Kojic, Snezana; Medeot, Elisa; Guccione, Ernesto; Krmac, Helena; Zara, Ivano; Martinelli, Valentina; Valle, Giorgio; Faulkner, Georgine. The Ankrd2 Protein, a Link Between the Sarcomere and the Nucleus in Skeletal Muscle. Journal of Molecular Biology. 2004-05, 339 (2) [2022-06-16]. doi:10.1016/j.jmb.2004.03.071. (原始內容存檔於2022-06-15) (英語). 
  2. ^ 2.0 2.1 Zhong, Sue; Delva, Laurent; Rachez, Christophe; Cenciarelli, Cristina; Gandini, Domenica; Zhang, Hui; Kalantry, Sundeep; Freedman, Leonard P.; Pandolfi, Pier Paolo. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins. Nature Genetics. 1999-11, 23 (3) [2022-06-16]. ISSN 1061-4036. PMID 10610177. doi:10.1038/15463. (原始內容存檔於2022-03-10) (英語). 
  3. ^ 3.0 3.1 Matsuzaki, Kazuhito; Minami, Takeshi; Tojo, Masahide; Honda, Yoshiomi; Saitoh, Noriko; Nagahiro, Shinji; Saya, Hideyuki; Nakao, Mitsuyoshi. PML-nuclear bodies are involved in cellular serum response. Genes to Cells: Devoted to Molecular & Cellular Mechanisms. 2003-03, 8 (3) [2022-06-16]. ISSN 1356-9597. PMID 12622724. doi:10.1046/j.1365-2443.2003.00632.x. (原始內容存檔於2022-06-16). 
  4. ^ Doucas, Vassilis; Tini, Marc; Egan, David A.; Evans, Ronald M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proceedings of the National Academy of Sciences. 1999-03-16, 96 (6) [2022-06-16]. ISSN 0027-8424. PMC 15819 . PMID 10077561. doi:10.1073/pnas.96.6.2627. (原始內容存檔於2022-06-16) (英語). 
  5. ^ Marcello, A. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. The EMBO Journal. 2003-05-01, 22 (9). PMC 156077 . PMID 12727882. doi:10.1093/emboj/cdg205. 
  6. ^ Ishov, Alexander M.; Sotnikov, Alexey G.; Negorev, Dmitri; Vladimirova, Olga V.; Neff, Norma; Kamitani, Tetsu; Yeh, Edward T.H.; Strauss, Jerome F.; Maul, Gerd G. Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1. Journal of Cell Biology. 1999-10-18, 147 (2) [2022-06-16]. ISSN 0021-9525. PMC 2174231 . PMID 10525530. doi:10.1083/jcb.147.2.221. (原始內容存檔於2022-06-16) (英語). 
  7. ^ Li, Hui; Leo, Christopher; Zhu, Jiang; Wu, Xiaoyang; O'Neil, Jennifer; Park, Eun-Ju; Chen, J. Don. Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML. Molecular and Cellular Biology. 2000-03, 20 (5) [2022-06-16]. ISSN 0270-7306. PMC 85360 . PMID 10669754. doi:10.1128/MCB.20.5.1784-1796.2000. (原始內容存檔於2021-11-28) (英語). 
  8. ^ Lehembre, François; Müller, Stefan; Pandolfi, Pier Paolo; Dejean, Anne. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene. 2001-01-04, 20 (1) [2022-06-16]. ISSN 0950-9232. PMID 11244500. doi:10.1038/sj.onc.1204063. (原始內容存檔於2021-08-11) (英語). 
  9. ^ Zhong, Sue; Salomoni, Paolo; Ronchetti, Simona; Guo, Ailan; Ruggero, Davide; Pandolfi, Pier Paolo. Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis. Journal of Experimental Medicine. 2000-02-21, 191 (4) [2022-06-16]. ISSN 0022-1007. PMC 2195846 . PMID 10684855. doi:10.1084/jem.191.4.631. (原始內容存檔於2022-06-16) (英語). 
  10. ^ Tsuzuki, Shinobu; Towatari, Masayuki; Saito, Hidehiko; Enver, Tariq. Potentiation of GATA-2 Activity through Interactions with the Promyelocytic Leukemia Protein (PML) and the t(15;17)-Generated PML-Retinoic Acid Receptor α Oncoprotein. Molecular and Cellular Biology. 2000-09, 20 (17) [2022-06-16]. ISSN 0270-7306. PMC 86102 . PMID 10938104. doi:10.1128/MCB.20.17.6276-6286.2000. (原始內容存檔於2022-06-16) (英語). 
  11. ^ 11.0 11.1 11.2 11.3 11.4 Khan, M. M.; Nomura, T.; Kim, H.; Kaul, S. C.; Wadhwa, R.; Shinagawa, T.; Ichikawa-Iwata, E.; Zhong, S.; Pandolfi, P. P.; Ishii, S. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Molecular Cell. 2001-06, 7 (6) [2022-06-16]. ISSN 1097-2765. PMID 11430826. doi:10.1016/s1097-2765(01)00257-x. (原始內容存檔於2021-11-28). 
  12. ^ 12.0 12.1 Wu, Wen-Shu; Vallian, Sadeq; Seto, Edward; Yang, Wen-Ming; Edmondson, Diane; Roth, Sharon; Chang, Kun-Sang. The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases. Molecular and Cellular Biology. 2001-04, 21 (7) [2022-06-16]. ISSN 0270-7306. PMC 86860 . PMID 11259576. doi:10.1128/MCB.21.7.2259-2268.2001. (原始內容存檔於2022-06-16) (英語). 
  13. ^ Topcu, Zeki; Mack, David L; Hromas, Robert A; Borden, Katherine LB. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control. Oncogene. 1999-11-25, 18 (50) [2022-06-16]. ISSN 0950-9232. PMID 10597310. doi:10.1038/sj.onc.1203201. (原始內容存檔於2022-06-16) (英語). 
  14. ^ Shin, Jinwook; Park, Boyoun; Cho, Sunglim; Lee, Sunray; Kim, Youngkyun; Lee, Seong-Ok; Cho, Kwangmin; Lee, Sungwook; Jin, Bong-Suk; Ahn, Jin-Hyun; Choi, Eui-Ju. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase. The Journal of Biological Chemistry. 2004-09-24, 279 (39) [2022-06-16]. ISSN 0021-9258. PMID 15273249. doi:10.1074/jbc.M407369200. (原始內容存檔於2022-06-16). 
  15. ^ Dahle, Øyvind; Bakke, Oddmund; Gabrielsen, Odd Stokke. c-Myb associates with PML in nuclear bodies in hematopoietic cells. Experimental Cell Research. 2004-07-01, 297 (1) [2022-06-16]. ISSN 0014-4827. PMID 15194430. doi:10.1016/j.yexcr.2004.03.014. (原始內容存檔於2022-06-16). 
  16. ^ 16.0 16.1 Kurki, Sari; Latonen, Leena; Laiho, Marikki. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. Journal of Cell Science. 2003-10-01, 116 (19) [2022-06-16]. ISSN 1477-9137. PMID 12915590. doi:10.1242/jcs.00714. (原始內容存檔於2022-06-16) (英語). 
  17. ^ 17.0 17.1 Bernardi, Rosa; Scaglioni, Pier Paolo; Bergmann, Stephan; Horn, Henning F.; Vousden, Karen H.; Pandolfi, Pier Paolo. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nature Cell Biology. 2004-07, 6 (7) [2022-06-16]. ISSN 1465-7392. PMID 15195100. doi:10.1038/ncb1147. (原始內容存檔於2022-06-17) (英語). 
  18. ^ Zhu, Hongyan; Wu, Liqing; Maki, Carl G. MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53. The Journal of Biological Chemistry. 2003-12-05, 278 (49) [2022-06-16]. ISSN 0021-9258. PMID 14507915. doi:10.1074/jbc.M308302200. (原始內容存檔於2022-06-16). 
  19. ^ Wei, Xiaolong; Yu, Zhong Kang; Ramalingam, Arivudainambi; Grossman, Steven R.; Yu, Jiang H.; Bloch, Donald B.; Maki, Carl G. Physical and functional interactions between PML and MDM2. The Journal of Biological Chemistry. 2003-08-01, 278 (31) [2022-06-16]. ISSN 0021-9258. PMID 12759344. doi:10.1074/jbc.M212215200. (原始內容存檔於2022-06-16). 
  20. ^ Wu, Wen-Shu; Xu, Zhi-Xiang; Ran, Ruixiang; Meng, Feng; Chang, Kun-Sang. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene. 2002-05-30, 21 (24) [2022-06-16]. ISSN 0950-9232. PMID 12032831. doi:10.1038/sj.onc.1205491. (原始內容存檔於2022-06-16) (英語). 
  21. ^ Hong, Suk-Hyun; Yang, Zhihong; Privalsky, Martin L. Arsenic Trioxide Is a Potent Inhibitor of the Interaction of SMRT Corepressor with Its Transcription Factor Partners, Including the PML-Retinoic Acid Receptor α Oncoprotein Found in Human Acute Promyelocytic Leukemia. Molecular and Cellular Biology. 2001-11, 21 (21) [2022-06-16]. ISSN 0270-7306. PMC 99892 . PMID 11585900. doi:10.1128/MCB.21.21.7172-7182.2001. (原始內容存檔於2021-08-11) (英語). 
  22. ^ Fogal, V. Regulation of p53 activity in nuclear bodies by a specific PML isoform. The EMBO Journal. 2000-11-15, 19 (22). PMC 305840 . PMID 11080164. doi:10.1093/emboj/19.22.6185. 
  23. ^ Guo, Ailan; Salomoni, Paolo; Luo, Jianyuan; Shih, Alan; Zhong, Sue; Gu, Wei; Paolo Pandolfi, Pier. The function of PML in p53-dependent apoptosis. Nature Cell Biology. 2000-10, 2 (10) [2022-06-16]. ISSN 1465-7392. PMID 11025664. doi:10.1038/35036365. (原始內容存檔於2022-06-16) (英語). 
  24. ^ Alcalay, Myriam; Tomassoni, Lucia; Colombo, Emanuela; Stoldt, Stephan; Grignani, Francesco; Fagioli, Marta; Szekely, Laszlo; Helin, Kristian; Pelicci, Pier Giuseppe. The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein. Molecular and Cellular Biology. 1998-02, 18 (2) [2022-06-16]. ISSN 0270-7306. PMC 108821 . PMID 9448006. doi:10.1128/MCB.18.2.1084. (原始內容存檔於2022-06-16) (英語). 
  25. ^ Kawasaki, Akira; Matsumura, Itaru; Kataoka, Yoshihisa; Takigawa, Eri; Nakajima, Koichi; Kanakura, Yuzuru. Opposing effects of PML and PML/RARα on STAT3 activity. Blood. 2003-05-01, 101 (9) [2022-06-16]. ISSN 1528-0020. PMID 12506013. doi:10.1182/blood-2002-08-2474. (原始內容存檔於2022-06-16) (英語). 
  26. ^ Lin, Ding-Yen; Shih, Hsiu-Ming. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration. The Journal of Biological Chemistry. 2002-07-12, 277 (28) [2022-06-16]. ISSN 0021-9258. PMID 11948183. doi:10.1074/jbc.M200633200. (原始內容存檔於2022-06-20). 
  27. ^ Kamitani, T.; Nguyen, H. P.; Kito, K.; Fukuda-Kamitani, T.; Yeh, E. T. Covalent modification of PML by the sentrin family of ubiquitin-like proteins. The Journal of Biological Chemistry. 1998-02-06, 273 (6) [2022-06-16]. ISSN 0021-9258. PMID 9452416. doi:10.1074/jbc.273.6.3117. (原始內容存檔於2022-06-20). 
  28. ^ Vallian, Sadeq; Chin, Khew-Voon; Chang, Kun-Sang. The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter. Molecular and Cellular Biology. 1998-12, 18 (12) [2022-06-16]. ISSN 0270-7306. PMC 109296 . PMID 9819401. doi:10.1128/MCB.18.12.7147. (原始內容存檔於2022-06-16) (英語). 
  29. ^ Xu, Zhi-Xiang; Timanova-Atanasova, Anna; Zhao, Rui-Xun; Chang, Kun-Sang. PML Colocalizes with and Stabilizes the DNA Damage Response Protein TopBP1. Molecular and Cellular Biology. 2003-06-15, 23 (12). ISSN 0270-7306. PMC 156140 . PMID 12773567. doi:10.1128/MCB.23.12.4247-4256.2003 (英語). 
  30. ^ Takahashi, Hidehisa; Hatakeyama, Shigetsugu; Saitoh, Hisato; Nakayama, Keiichi I. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. The Journal of Biological Chemistry. 2005-02-18, 280 (7) [2022-06-16]. ISSN 0021-9258. PMID 15569683. doi:10.1074/jbc.M408130200. (原始內容存檔於2022-06-16). 
  31. ^ Koken, M. H. M.; Reid, A.; Quignon, F.; Chelbi-Alix, M. K.; Davies, J. M.; Kabarowski, J. H. S.; Zhu, J.; Dong, S.; Chen, S.-J.; Chen, Z.; Tan, C. C. Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proceedings of the National Academy of Sciences. 1997-09-16, 94 (19) [2022-06-16]. ISSN 0027-8424. PMC 23349 . PMID 9294197. doi:10.1073/pnas.94.19.10255. (原始內容存檔於2022-06-16) (英語). 

延伸閱讀

外部連結